Published in

American Association for the Advancement of Science, Science Translational Medicine, 593(13), 2021

DOI: 10.1126/scitranslmed.abf1906

Links

Tools

Export citation

Search in Google Scholar

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Journal article published in 2021 by Bryan E. Jones ORCID, Patricia L. Brown-Augsburger ORCID, Kizzmekia S. Corbett ORCID, Kathryn Westendorf ORCID, Julian Davies ORCID, Thomas P. Cujec ORCID, Christopher M. Wiethoff ORCID, Jamie L. Blackbourne ORCID, Beverly A. Heinz, Denisa Foster, Richard E. Higgs ORCID, Deepa Balasubramaniam ORCID, Lingshu Wang, Yi Zhang ORCID, Eun Sung Yang ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

LY-CoV555, a SARS-CoV-2 spike protein–specific antibody, neutralizes SARS-CoV-2 and protects the airways of nonhuman primates against infection.